Cliff Tapp

CEO

Senior executive with 18 years fundraising, team and stakeholder management experience, with focus on bio sciences, sustainability, and innovation technologies.

Experienced matrix manager creating teams to efficiently execute research projects, control funds and deliver on key milestones.

Globally networked with angel and venture capital investors/UHNWI connections in the UK, US, Singapore, Malaysia, India and the Middle East. 

Wesley Smith

CTO

Professional biotechnologist with 20 years of industrial experience including diverse scientific skills, R&D / pipeline management. Aurealis therapeutics, VTT, Ipsat, Institute of Biotechnology, & Abbott.

Extensive experience with mammalian cells and heterologous growth factor functionality with multiple complex mechanisms of action.

Strong background In IMP/IND drug development, CMC, and GMP in compliance with ICH guidelines for EMA and FDA approval process.​